Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Research from Institute Pasteur yields new findings on vaccines
December 17th, 2008
Research findings, 'Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path,' are discussed in a new report. "Following several decades of research, there is not yet a convincing vaccine against shigellosis. It is still difficult, in spite of the breadth of strategies (i.e. live attenuated oral, killed oral, subunit parenteral) to select an optimal option," researchers in France report. "Two approaches are clearly emerging: (i) live attenuated deletion mutants based on rational selection of genes that are key in the pathogenic process, and (ii) conjugated detoxified polysaccharide parenteral vaccines, or more recently...
Source: Vaccine Weekly (2008-12-17)
|
